A controlled, cross-sectional exploratory study on markers for the plasminogen system and inflammation in crevicular fluid samples from healthy, mucositis and peri-implantitis sites

European Journal of Oral Implantology

Volumn 8, Issue 2, 2015, Pages 153-166

  Hall, Jan ^a   Pehrson, Nils Gunnar ^b   Ekestubbe, Annika ^c   Jemt, Torsten ^c,d   Friberg, Bertil ^c  

^a Nobel Biocare   (Sweden)

^b Statistical Consultancy Group   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d BRÅNEMARK CLINIC   (Sweden)

Author keywords

IL 1 ; IL 8; Mucositis; PAI 2; Peri implantitis; Plasminogen system; qPCR; TPA

Indexed keywords

ACID PHOSPHATASE; BIOLOGICAL MARKER; CATHEPSIN K; IL8 PROTEIN, HUMAN; INTERLEUKIN 1BETA; INTERLEUKIN 8; ISOENZYME; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 2; SERINE PROTEINASE INHIBITOR; TARTRATE-RESISTANT ACID PHOSPHATASE; TISSUE PLASMINOGEN ACTIVATOR; TOOTH IMPLANT;

ADULT; AGED; BONE REMODELING; CHEMISTRY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; OSTEOLYSIS; PERI-IMPLANTITIS; PHYSIOLOGY; STOMATITIS; SUPPURATION; TOOTH IMPLANT; VERY ELDERLY;

ACID PHOSPHATASE; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BONE REMODELING; BONE RESORPTION; CATHEPSIN K; CROSS-SECTIONAL STUDIES; DENTAL IMPLANTS; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; ISOENZYMES; MALE; MIDDLE AGED; PERI-IMPLANTITIS; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 2; SERINE PROTEINASE INHIBITORS; STOMATITIS; SUPPURATION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84964696605     PISSN: 17562406     EISSN: 17562414     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Esposito M, Grusovin MG, Worthington HV. Treatment of periimplantitis: what interventions are effective? A Cochrane systematic review. Eur J Oral Implantol 2012;5(Suppl):S21-S41.
2. Faggion CM Jr, Chambrone L, Listl S, Tu YK. Network metaanalysis for evaluating interventions in implant dentistry: the case of peri-implantitis treatment. Clin Implant Dent Relat Res 2013;15:576-588.
3. Roos-Jansåker AM, Renvert H, Lindahl C, Renvert S. Surgical treatment of peri-implantitis using a bone substitute with or without a resorbable membrane: a prospective cohort study. J Clin Periodontol 2007;34:625-632.
4. Leonhardt Å, Dahlén G, Renvert S. Five-year clinical, microbiological, and radiological outcome following treatment of peri-implantitis in man. J Periodontol 2003;74:1415-1422.
5. Esposito M, Grusovin MG, De Angelis N, Camurati A, Campailla M, Felice P. The adjunctive use of light-activated disinfection (LAD) with FotoSan is ineffective in the treatment of peri-implantitis: 1-year results from a multicentre pragmatic randomised controlled trial. Eur J Oral Implantol 2013;6:109-119.
6. Renvert S, Roos-Jansåker AM, Claffey N. Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review. J Clin Periodontol 2008;35(Suppl 8):305-315.
7. Claffey N, Clarke E, Polyzois I, Renvert S. Surgical treatment of peri-implantitis. J Clin Periodontol 2008;35(Suppl 8):316-332.
8. Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. Int J Oral Maxillofac Implants 1996;11:794-799.
9. Kao RT, Curtis DA, Richards DW, Preble J. Increased interleukin-1β in the crevicular fluid of diseased implants. Int J Oral Maxillofac Implants 1995;10:696-701.
10. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, Takeda H, Araki H, Shin K, Okuda K, Miyata T, Yoshie H. Osteocalcin, deoxypyridinoline and interleukin-1β in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Impl Res 2002;13:637-643.
11. Hultin M, Gustafsson A, Hallström H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002;13:349-358.
12. Nassar H, Chou HH, Khlgatian M, Gibson FC 3rd, Van Dyke TE, Genco CA. Role for fimbriae and lysine-specific cysteine poteinase gingipain K in expression of Interleukin- 8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 2002;70:268-276.
13. Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid Interleukin-6 and Interleukin-8 levels in chronic periodontitis. Int J Dent 2012;2012:362905.
14. Petkovic AB, Matic SM, Stamatovic NV, Vojvodic DV, Todorovic TM, Lazic ZR, Kozomara RJ. Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP- 1alpha) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg 2010;39:478-485.
15. Nowzari H, Botero JE, DeGiacomo M, Villacres MC, Rich SK. Microbiology and cytokine levels around healthy dental implants and teeth. Clin Implant Dent Relat Res 2008;10:166-173.
16. Collen D. The plasminogen (fibrinolytic) system. Thromb Haemost 1999;82:259-270.
17. Syrovets T, Lunov O, Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol 2012;92:509-519.
18. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996;2:287-292.
19. Kinnby B. The Plasminogen activating system in periodontal health and disease. Biol Chem 2002;383:85-92.
20. Kinnby B, Matsson L, Astedt B. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. J Periodontal Res 1996;31: 271-277.
21. Olofsson A, Matsson L, Kinnby B. Plasminogen activating capacity in gingival fluid from deteriorating and stable periodontal pockets. J Periodontal Res 2002;37:60-65.
22. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285-290.
23. Strbac GD, Monov G, Cei S, Kandler B, Watzek G, Gruber R. Cathepsin K levels in the crevicular fluid of dental implants: a pilot study. J Clin Periodontol 2006;33:302-308.
24. Yamalik N, Günday S, Kilinic K, Karabulut E, Berker E, Tösüm TF. Analysis of cathepsin-K levels in biologic fluids from healthy or diseased natural teeth and dental implants. Int J Oral Maxillofac Implants 2011;26:991-997.
25. Hall J, Britse AO, Jemt T, Friberg B. A controlled clinical exploratory study on genetic markers for peri-implantitis. Eur J Oral Implantol 2011;4:371-382.
26. Vandenbroucke JP, von Elm E, Altman DG, GØtzsche PC, Mulrow CD , Pocock SJ, Poole C, Schlesselman JJ, Egger M, STROBE Initiative. Strengthening the reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. 2007;PLoS Med 4:e297.
27. Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P. Strengthening the reporting of observational studies in epidemiology - Molecular epidemiology (STROBE-ME): An extension of the STROBE statement 2011;PLoS Med 8:e1001117.
28. Mombelli A, van Oosten MA, Schurch E Jr, Lang NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987;2:145-151.
29. Livak K, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-δC(T)) method. Methods 2001;25:402-408.
30. NormFinder software. Available at: http://www.mdl.dk/ publicationsnormfinder.htm. Accessed 29 November 2011.
31. Shen Y, Guo Y, Mikus P, Sulniute R, Wilczynska M, Ny T, Li J. Plasminogen is a key proinflammatory regulator that accelerates the healing of acute and diabetic wounds. Blood 2012;119:5879-5887.
32. Yin X, Bunn CL, Barthold PM. Detection of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in gingival crevicular fluid from healthy, gingivitis and periodontitis patients. J Clin Periodontol 2000;27:149-156.
33. Toyman U, Tüter G, Kurtis B, Kivrak E, Bozkurt S, Yücel AA, Serdar M. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-ß in patients with different periodontal diseases. J Periodont Res 2015;50:44-51.
34. Becker S, Beck-Broichsitter B, Graetz C, Dörfer CE, Wiltfang J, Häsler R. Peri-implantitis versus periodontitis: functional differences indicated by transcriptome profiling. Clin Implant Dent Relat Res 2014;16:401-411.
35. Goodson JM, Tanner AC, Haffajee AD, Sornberger GC, Socransky SS. Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontol 1982;9:472-481.
36. Lindhe J, Haffajee AD, Socransky SS. Progression of periodontal disease in adult subjects in the absence of periodontal therapy. J Clin Periodontol 1983;10:433-442.
37. Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol 1984;11:21-32.
38. Ahlqvist J, Borg K, Gunne J, Nilson H, Olsson M, Astrand P. Osseointegrated implants in edentulous jaws: a 2-year longitudinal study. Int J Oral Maxillofac Implants 1990;5:155-163.
39. Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: a review and proposed criteria of success. Int J Oral Maxillofac Implants 1986;1:11-25.
40. Albrektsson T, Zarb GA. Current interpretations of the osseointegrated response: clinical significance. Int J Prosthodont 1993;6:95-105.